Google Ventures is another of the investors, as well as Deerfield Management, Viking Global Investors, Fidelity Management & Research Company, Jennison Associates (on behalf of clients), Khosla Ventures, EcoR1 Capital, Casdin Capital, Omega Funds, Cowen Private Investments and Alexandria Venture Investments.Įditas’ founding investors, Flagship Ventures, Polaris Partners, Third Rock Ventures, and Partners Innovation Fund, also participated in this round of financing. He is now an Editas board members, as well as MD of nb0, a US investment company founded specifically to fund Editas Medicine. The technology is more sophisticated and precise than other “knock-out” methods.Įditas’ investor syndicate is led by Boris Nikolic, former chief science and technology advisor to Bill Gates at his private office, bgC3, and at the Gates Foundation, where Nikolic selected investment projects in life sciences and health. When the Cas9 protein reaches its target, it can directly turn on or off disease-causing genes. The $120m funding round from a large group of public and private investors, will go towards expanding Editas’ gene-editing platform for multiple disease programmes.ĬRISPR-Cas9 is a tool which allows modification of human DNA, using an enzyme called Cas9 attached to an RNA molecule which guides it to a particular genome sequence.
0 Comments
Leave a Reply. |